The move combines Epsilogen’s clinical focus on immunoglobulin E (IgE) antibodies with TigaTx’s work on immunoglobulin A (IgA ...

IGG Inc (IGGGF) reported a significant increase in annual revenue, reaching 5.74 billion Hong Kong dollars, marking a 9% worldwide increase. The company's APP business saw substantial growth, with ...

Epsilogen completes acquisition of TigaTx to create world’s leading pan-isotype cancer antibody company: London Tuesday, April 8, 2025, 10:00 Hrs [IST] Epsilogen, the global lea ...